| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Apr 15, 2024 | Sale | $39.52 | 39,164 | 1,547,639 | 227,704 | Apr 17, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Prasad Raju | Chief Financial Officer | Mar 15, 2024 | Sale | $72.69 | 3,524 | 256,160 | 6,476 | Mar 18, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 15, 2024 | Sale | $45.80 | 40,000 | 1,832,028 | 228,122 | Mar 18, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 12, 2024 | Sale | $74.44 | 1,146 | 85,308 | 61,174 | Mar 12, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 11, 2024 | Sale | $78.26 | 2,801 | 219,206 | 60,070 | Mar 12, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 11, 2024 | Sale | $78.26 | 9,802 | 767,105 | 203,705 | Mar 12, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 12, 2024 | Sale | $74.44 | 4,583 | 341,159 | 208,122 | Mar 12, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | George Simeon | Director | Feb 27, 2024 | Option Exercise | $71.50 | 63,177 | 4,517,156 | 63,177 | Feb 27, 2024, 06:39 PM | |
| CRSP | CRISPR Therapeutics AG | George Simeon | Director | Feb 27, 2024 | Option Exercise | $71.50 | 216,578 | 15,485,327 | 216,578 | Feb 27, 2024, 06:39 PM | |
| CRSP | CRISPR Therapeutics AG | George Simeon | Director | Feb 27, 2024 | Option Exercise | $71.50 | 769,196 | 54,997,514 | 769,196 | Feb 27, 2024, 06:39 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Feb 20, 2024 | Sale | $79.67 | 1,913 | 152,409 | 57,371 | Feb 21, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 20, 2024 | Sale | $79.67 | 6,370 | 507,498 | 194,257 | Feb 21, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 15, 2024 | Sale | $49.74 | 40,000 | 1,989,577 | 207,377 | Feb 16, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 29, 2024 | Sale | $39.82 | 100,000 | 3,981,573 | 237,377 | Jan 31, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 16, 2024 | Option Exercise | $40.81 | 40,000 | 1,632,458 | 207,377 | Jan 18, 2024, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | May 30, 2023 | Sale | $42.00 | 50,000 | 2,099,894 | 412,377 | Jun 01, 2023, 05:44 PM | |
| CRSP | CRISPR Therapeutics AG | Morrow Phuong Khanh | Chief Medical Officer | May 24, 2023 | Option Exercise | $65.91 | 2,527 | 166,555 | 4,411 | May 25, 2023, 05:35 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Apr 25, 2023 | Sale | $34.89 | 50,000 | 1,744,638 | 412,377 | Apr 27, 2023, 05:37 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 29, 2023 | Sale | $31.79 | 50,000 | 1,589,504 | 412,377 | Mar 31, 2023, 05:49 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 13, 2023 | Option Exercise | $43.22 | 9,444 | 408,170 | 387,377 | Mar 14, 2023, 05:47 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 13, 2023 | Option Exercise | $43.22 | 2,305 | 99,622 | 54,844 | Mar 14, 2023, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 27, 2023 | Sale | $33.68 | 50,000 | 1,684,243 | 400,988 | Mar 01, 2023, 06:11 PM | |
| CRSP | CRISPR Therapeutics AG | Smith Brendan | Chief Financial Officer | Feb 21, 2023 | Option Exercise | $48.26 | 1,392 | 67,178 | 5,072 | Feb 22, 2023, 05:41 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Feb 21, 2023 | Option Exercise | $48.26 | 6,373 | 307,561 | 375,988 | Feb 22, 2023, 05:38 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Feb 21, 2023 | Option Exercise | $48.26 | 1,950 | 94,107 | 52,066 | Feb 22, 2023, 05:35 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 27, 2023 | Option Exercise | $35.30 | 50,000 | 1,764,798 | 394,111 | Jan 31, 2023, 05:34 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 28, 2022 | Sale | $30.03 | 50,000 | 1,501,290 | 394,111 | Dec 30, 2022, 05:33 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 06, 2022 | Option Exercise | $1.81 | 58,233 | 105,402 | 369,111 | Dec 08, 2022, 05:35 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 05, 2022 | Option Exercise | $52.26 | 19,401 | 1,013,896 | 310,878 | Dec 06, 2022, 05:49 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Dec 05, 2022 | Option Exercise | $52.26 | 3,234 | 169,009 | 50,191 | Dec 06, 2022, 05:47 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Nov 28, 2022 | Sale | $36.58 | 50,000 | 1,828,827 | 315,279 | Nov 30, 2022, 05:36 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Oct 26, 2022 | Sale | $35.82 | 50,000 | 1,791,207 | 315,279 | Oct 28, 2022, 05:43 PM | |
| CRSP | CRISPR Therapeutics AG | Smith Brendan | Chief Financial Officer | Oct 17, 2022 | Option Exercise | $55.76 | 1,111 | 61,949 | 2,639 | Oct 18, 2022, 05:38 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Sep 28, 2022 | Sale | $40.41 | 50,000 | 2,020,410 | 315,279 | Sep 30, 2022, 05:42 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 29, 2022 | Sale | $41.53 | 50,000 | 2,076,334 | 315,279 | Aug 31, 2022, 05:45 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jul 27, 2022 | Sale | $45.45 | 50,000 | 2,272,665 | 315,279 | Jul 29, 2022, 05:38 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 29, 2022 | Sale | $37.08 | 50,000 | 1,854,111 | 315,279 | Jul 01, 2022, 06:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 11, 2022 | Option Exercise | $62.56 | 5,487 | 343,267 | 285,432 | Mar 14, 2022, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 14, 2022 | Option Exercise | $61.08 | 4,153 | 253,665 | 290,279 | Mar 14, 2022, 06:12 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Mar 11, 2022 | Option Exercise | $62.56 | 1,883 | 117,800 | 25,026 | Mar 14, 2022, 06:03 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Mar 14, 2022 | Option Exercise | $61.08 | 1,229 | 75,067 | 26,797 | Mar 14, 2022, 06:03 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 14, 2022 | Option Exercise | $61.08 | 1,039 | 63,462 | 46,429 | Mar 14, 2022, 06:01 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 11, 2022 | Option Exercise | $62.56 | 1,321 | 82,642 | 45,218 | Mar 14, 2022, 06:01 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 20, 2021 | Option Exercise | $1.81 | 17,750 | 32,127 | 279,085 | Dec 22, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 06, 2021 | Option Exercise | $69.17 | 37,818 | 2,615,871 | 261,335 | Dec 07, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Dec 06, 2021 | Option Exercise | $69.17 | 11,185 | 773,666 | 22,325 | Dec 07, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Ho Tony W | Executive VP, Head of R&D | Dec 06, 2021 | Option Exercise | $69.17 | 12,607 | 872,026 | 52,364 | Dec 07, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Dec 06, 2021 | Option Exercise | $69.17 | 6,303 | 435,978 | 43,542 | Dec 07, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Dec 02, 2021 | Option Exercise | $13.62 | 7,342 | 99,998 | 36,512 | Dec 03, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 01, 2021 | Option Exercise | $75.10 | 779 | 58,503 | 219,153 | Dec 03, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Oct 15, 2021 | Option Exercise | $1.81 | 33,000 | 59,730 | 219,932 | Oct 18, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Sep 13, 2021 | Option Exercise | $117.86 | 4,741 | 558,774 | 29,170 | Sep 14, 2021, 09:45 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Sep 13, 2021 | Option Exercise | $117.86 | 4,207 | 495,837 | 6,843 | Sep 14, 2021, 09:44 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Sep 01, 2021 | Option Exercise | $124.83 | 787 | 98,241 | 186,932 | Sep 03, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | TOMSICEK MICHAEL JOHN | Chief Financial Officer | Aug 06, 2021 | Sale | $78.13 | 50,000 | 3,906,676 | 26,891 | Aug 10, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 04, 2021 | Option Exercise | $68.79 | 3,000 | 206,385 | 189,219 | Aug 06, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Aug 05, 2021 | Sale | $70.78 | 57,000 | 4,034,184 | 216,219 | Aug 06, 2021, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Jul 19, 2021 | Sale | $126.43 | 10,000 | 1,264,345 | 155,327 | Jul 21, 2021, 05:21 PM | |
| CRSP | CRISPR Therapeutics AG | Novak Rodger | President | Jun 30, 2021 | Sale | $165.00 | 25,000 | 4,125,000 | 573,007 | Jul 01, 2021, 05:43 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Jun 29, 2021 | Sale | $149.49 | 47,536 | 7,106,339 | 46,136 | Jun 30, 2021, 06:41 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Jun 28, 2021 | Sale | $152.48 | 20,375 | 3,106,783 | 17,159 | Jun 30, 2021, 06:38 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Jun 28, 2021 | Sale | $152.48 | 10,000 | 1,524,799 | 167,253 | Jun 30, 2021, 06:38 PM | |
| CRSP | CRISPR Therapeutics AG | Novak Rodger | President | Jun 28, 2021 | Sale | $156.55 | 25,000 | 3,913,750 | 598,007 | Jun 30, 2021, 05:33 PM | |
| CRSP | CRISPR Therapeutics AG | Novak Rodger | President | Jun 21, 2021 | Sale | $128.62 | 25,000 | 3,215,458 | 646,836 | Jun 23, 2021, 05:54 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jun 15, 2021 | Sale | $69.50 | 60,000 | 4,169,904 | 217,719 | Jun 17, 2021, 05:44 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Mar 23, 2021 | Option Exercise | $84.97 | 188,000 | 15,975,240 | 101,050 | Mar 25, 2021, 05:39 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Mar 22, 2021 | Sale | $132.37 | 30,374 | 4,020,669 | 57,149 | Mar 24, 2021, 06:00 PM | |
| CRSP | CRISPR Therapeutics AG | TOMSICEK MICHAEL JOHN | Chief Financial Officer | Mar 10, 2021 | Option Exercise | $124.15 | 1,352 | 167,851 | 1,891 | Mar 12, 2021, 05:50 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 10, 2021 | Option Exercise | $124.15 | 5,526 | 686,053 | 188,498 | Mar 12, 2021, 05:49 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Mar 10, 2021 | Option Exercise | $124.15 | 2,141 | 265,805 | 13,050 | Mar 12, 2021, 05:47 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Mar 10, 2021 | Option Exercise | $124.15 | 1,353 | 167,975 | 23,911 | Mar 12, 2021, 05:43 PM | |
| CRSP | CRISPR Therapeutics AG | Ho Tony W | Executive VP, Head of R&D | Mar 10, 2021 | Option Exercise | $124.15 | 2,141 | 265,805 | 38,304 | Mar 12, 2021, 05:41 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Jan 15, 2021 | Option Exercise | $14.43 | 16,334 | 235,700 | 26,942 | Mar 12, 2021, 05:37 PM | |
| CRSP | CRISPR Therapeutics AG | Ho Tony W | Executive VP, Head of R&D | Mar 05, 2021 | Option Exercise | $114.65 | 1,585 | 181,720 | 35,862 | Mar 09, 2021, 05:40 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Mar 01, 2021 | Option Exercise | $130.25 | 798 | 103,940 | 182,191 | Mar 03, 2021, 04:13 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Feb 19, 2021 | Sale | $149.11 | 171,003 | 25,497,851 | 261,634 | Feb 23, 2021, 12:00 AM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Jan 15, 2021 | Sale | $107.74 | 40,000 | 4,309,511 | 202,989 | Jan 20, 2021, 06:11 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Jan 15, 2021 | Sale | $114.47 | 50,010 | 5,724,715 | 36,334 | Jan 20, 2021, 06:07 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Jan 19, 2021 | Sale | $128.22 | 55,000 | 7,051,919 | 49,931 | Jan 20, 2021, 06:05 PM | |
| CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | CBO & COO | Jan 02, 2021 | Option Exercise | $153.11 | 9,392 | 1,438,009 | 10,608 | Jan 04, 2021, 04:12 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 29, 2020 | Option Exercise | $1.81 | 13,800 | 24,978 | 182,989 | Dec 30, 2020, 04:02 PM | |
| CRSP | CRISPR Therapeutics AG | Ho Tony W | Executive VP, Head of R&D | Dec 21, 2020 | Sale | $83.07 | 47,102 | 3,912,622 | 57,515 | Dec 22, 2020, 04:55 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Dec 16, 2020 | Sale | $148.95 | 7,648 | 1,139,176 | 6,734 | Dec 18, 2020, 07:12 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Dec 16, 2020 | Sale | $148.95 | 7,352 | 1,095,087 | 346,308 | Dec 18, 2020, 07:12 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Dec 10, 2020 | Sale | $143.35 | 33,000 | 4,730,442 | 38,377 | Dec 17, 2020, 07:14 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Dec 10, 2020 | Sale | $143.35 | 33,000 | 4,730,442 | 344,915 | Dec 14, 2020, 07:11 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 10, 2020 | Sale | $72.05 | 40,000 | 2,881,982 | 189,189 | Dec 11, 2020, 04:05 PM | |
| CRSP | CRISPR Therapeutics AG | KASINGER JAMES R. | General Counsel and Secretary | Dec 09, 2020 | Option Exercise | $13.62 | 22,026 | 299,994 | 22,415 | Dec 10, 2020, 04:35 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Dec 07, 2020 | Sale | $154.53 | 171,004 | 26,424,493 | 513,381 | Dec 09, 2020, 07:54 PM | |
| CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Officer | Dec 01, 2020 | Option Exercise | $129.58 | 779 | 100,943 | 169,189 | Dec 03, 2020, 04:32 PM | |
| CRSP | CRISPR Therapeutics AG | Novak Rodger | President | Nov 30, 2020 | Sale | $69.61 | 200,000 | 13,921,500 | 698,007 | Dec 02, 2020, 04:26 PM | |
| CRSP | CRISPR Therapeutics AG | Novak Rodger | President | Oct 08, 2020 | Sale | $57.22 | 44,476 | 2,544,694 | 670,245 | Oct 13, 2020, 04:44 PM | |
| CRSP | CRISPR Therapeutics AG | Novak Rodger | President | Oct 09, 2020 | Sale | $57.22 | 5,524 | 316,056 | 650,769 | Oct 13, 2020, 04:44 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Sep 18, 2020 | Sale | $86.87 | 3,035 | 263,636 | 518,190 | Sep 22, 2020, 08:10 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Sep 16, 2020 | Sale | $86.98 | 8,965 | 779,778 | 521,225 | Sep 18, 2020, 04:30 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Sep 14, 2020 | Sale | $84.89 | 1,155 | 98,045 | 530,190 | Sep 16, 2020, 08:00 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Sep 10, 2020 | Sale | $85.36 | 22,845 | 1,949,996 | 540,029 | Sep 11, 2020, 09:49 PM | |
| CRSP | CRISPR Therapeutics AG | Bolzon Bradley J PhD | Director | Sep 01, 2020 | Option Exercise | $58.87 | 120,000 | 7,064,594 | 60,000 | Sep 03, 2020, 09:21 PM | |
| CRSP | CRISPR Therapeutics AG | TOMSICEK MICHAEL JOHN | Chief Financial Officer | Sep 01, 2020 | Sale | $55.00 | 24,000 | 1,320,068 | 12,410 | Sep 03, 2020, 04:46 PM | |
| CRSP | CRISPR Therapeutics AG | Novak Rodger | President | Sep 01, 2020 | Sale | $53.49 | 50,000 | 2,674,636 | 673,007 | Sep 03, 2020, 04:44 PM |
Menu